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open sinus lift is used to augment the maxillary sinus prior to implant Placement in patients with sinus pneumatization due to early extraction of upper molars Where the remaining available bone length is from zero to
6 mm which will not accommodate for implant placement and not suﬃcient for implant initial stability so we
will need to do Sinus lift and augmentation of the sinus with various bone grafts either (alloplast, allograft,
Autogenous). Search is conducted electronically on line in pub med & Cochrane and manual Search was also
done from 2007 to 2018 the articles included assisting &evaluating various types of bone substitute used in open
sinus lift surgeries.197 papers are identiﬁed through data base searching 37 Additional records identiﬁed
through manual search, after duplication removal the remaining papers are 187,187 paper were reviewed&152
were excluded by title &abstract, 35 article were reviewed as full text, 27 articles were excluded by reason, 8
articles were included in this study, Eight included articles have revealed new bone formation with percentage
ranges from 48%as the highest percentage&16.4 as the lowest percentage, residual material ranges from 6.3%to
34.8% which diﬀers according to type of bone graft used, histological evaluation is performed in 7 articles in
addition to radiological evaluation only one article used radiographic evaluation only This systematic review
supported the fact that bone substitute act as a scaﬀold for new bone formation with diﬀerent percentages
according to type of bone substitute used.

1. Introduction
After extraction of teeth in posterior maxilla alveolar bone resorption takes place as well as maxillary sinus pneumatization results in
bone loss. Long term survival and success of dental implant requires
primary stability and appropriate bone volume [1]. It was clearly demonstrated that implants placed in poor bone quality have higher
failure rates than implant placed in higher bone quality [2,3]. Implants
placed in posterior region of maxilla showed the lowest success. The
poorest bone density exists in posterior region of the maxilla therefore it
is associated with the highest failure rates [3,4].Misch has revealed that
bone density of the implant bed is an important factor in determining
the treatment plan; implant design, surgical approach, healing time and
initial progressive bone loading during prosthetic reconstruction.
He classiﬁed bone density: D1: Dense cortical bone. D2:Thick dense
to porous cortical bone on the crest and coarse trabecular bone within.
D3: Thin porous cortical bone on the crest and ﬁne trabecular bone
within. D4: Fine trabecular bone. D5: Immature, non-mineralized bone
[5,6].Bone quality is classiﬁed into 4 categories according to lecholm

and zarb [7] Type I: composed of homogenous compact bone. Type II:
composed of thick layer of compact bone surrounding a core of dense
trabecular bone. Type III: composed of thin layer of cortical bone surrounding dense trabecular bone. Type IV: composed of a thin layer of
cortical bone surrounding a low density core of trabecular bone. Gaﬃn
and Berman reported 55% of all implant failure occurred in type IV
bone [8]Increasing bone volume in posterior maxilla and bone quality
has been achieved by combining various procedures and materials [9].
Elevation and augmentation of the maxillary sinus can increase the
bone height in the posterior area of the maxilla [10].
At the Consensus Conference on Maxillary Sinus Elevation in 1996
[11] the members made the following recommendations which depend
on the residual bone height (RBH):

• Category A (RBH ≥ 10 mm): classic implant procedure
• Category B (RBH ≥ 7–9 mm): osteotome technique with simultaneous placement of implants
• Category C (RBH ≥ 4–6 mm): maxillary sinus elevation with lateral

access and bone graft and immediate or deferred placement of
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implants

dissolution kinetics, and strong stimulatory eﬀect on osteoblast diﬀerentiation suggest wide applications of SCPC in the ﬁeld of bone tissue
reconstruction in maxillofacial surgeries.
The current study reviews the literature of application various types
of bone substitute used for augmentation of the maxillary sinus by
searching on Electronic Search engines are Pub Med and Cochrane.
Manual search was done in the libraries of the Faculty of Oral & Dental
Medicine, Cairo University; Faculty of Oral and Dental Medicine, AlAzhar University; and the Faculty of Oral & Dental Medicine, Future
University in Egypt.

• Category D (RBH ≥ 1–3 mm): maxillary sinus elevation with lateral
access and bone graft and deferred placement of implants

During the maxillary sinus ﬂoor elevation procedure, the space
created between the residual maxillary ridge and the elevated
Schneiderian membrane is usually ﬁlled with grafting material ([12]
[13]). In this way, a bone fraction is created that may allow for reliable
implant placement, either simultaneously with the elevation procedure
when the residual ridge allows for primary implant stability or as a
second stage after healing of the grafted site [14].
Bone grafting materials are generally classiﬁed as autografts, allografts, xenografts and alloplasts. Out of these, autografts harvested from
the patient's own body (chin, hip, ribs etc) are regarded “gold standard”
[15,16]. Because of the lack of antigenicity of the graft material osteoconduction&osteoinduction. Allografts are transplants from a genetically non identical individual of same species which are “converted” to self by the host [16,17].
Xenografts are transplants from one species to another. Bovine derived bone is a good example of xenograft. Alloplasts are synthetic
chemically derived bone substitute. Most often this material is a form of
calcium phosphate. Although autograft material is currently the material of choice, there are limitations associated with its use, including
donor site morbidity, limited donor bone supply, anatomical and
structural problems, Band elevated levels of resorption during healing
[18].
The use of allografts has the disadvantage of eliciting an immunological response due to genetic diﬀerences and the risk of inducing transmissible diseases [18,19]. Calcium phosphate ceramics and
bioactive glasses were introduced more than 30 years ago as bone
substitutes. These materials are considered bioactive because they bond
to bone and enhance bone tissue formation.
The forms of calcium phosphate ceramics most widely used are
tricalcium phosphate (B-TCP)and hydroxyapatite (HA). These materials
have a similar structure to the mineral phase of bone and have been
shown to be osteoconductive, i.e., enhance bone cells growth and direct
bone deposition on their surfaces. The availability of HA and TCP in
porous shapes has encouraged many investigators to evaluate the
ability of these biomaterials to serve as tissue engineering scaﬀolds for
cell and drug delivery.
However, there were setbacks. Hydroxyapatite is known to exhibit
limited osteoconduction and has a slow rate of degradation in physiological solutions because of its chemical stability [20,21]. On the other
hand, B -TCP is plagued by an unpredictable, fast rate of dissolution
that may lead to an immunological response [22].
Bioactive glass (BG), which contains (45 wt %) of silica in addition
to calcium and phosphorous, is known to have the most stimulatory
eﬀect on bone cell function [23,24].
Unfortunately, there is a limited opportunity to synthesize a porous
BG and improve its mechanical and physicochemical properties without
decrements in bioactivity.
Recently, a novel porous silica–calcium phosphate nanocomposite
(SCPC) has been proposed as a candidate for bone tissue engineering
scaﬀold. The new resorbable porous bioactive silica-calcium phosphate
composite has the ability to absorb high quantities of serum protein and
stimulate rapid bone generation. The high porosity of the SCPC enhanced cell colonization and bone formation on and within the graft
material. The high rate of silica dissolution from SCPC promoted rapid
bone regeneration and graft material resorption. Thermal treatment of
the SCPC induced ion substitution and formation of solid solutions at
signiﬁcantly low temperature. These ultra structural modiﬁcations facilitated protein adsorption and controlled SCPC solubility [25,26].
It has been demonstrated that SCPC has a superior bone regenerative capacity and resorbability when compared to HA and
bioactive glass.
The nanoporous structure, superior bioactivity, controlled
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2. Materials & methods
Publications on the subject were searched up to.2018on electronic
database (Cochrane & pub med) the keywords used are
1 "Sinus ﬂoor augmentation" [Mesh]
2 (((Calcium phosphate ceramics))) or ((Bioceramics)) and (Bone
Augmentation)
3 (((Bone augmentation))) and ((Hyd\roxyapatite))
4 (((Hydroxyapatite))) and ("Sinus ﬂoor augmentation") Mesh
The Manual search was done in the libraries of the Faculty of Oral
& Dental Medicine, Cairo University; Faculty of Oral and Dental
Medicine, Al-Azhar University; and the Faculty of Oral & Dental
Medicine, Future University in Egypt.

•

2.1. Study selection
The PRISMA ﬂow diagram in (Fig. 1) presents an overview of the
selection process. The titles of identiﬁed reports were initially screened.
The abstract was assessed when the title indicated that the study fulﬁlled the inclusion criteria. A full-text analysis was performed when the
abstract was unavailable or when the abstract indicated that the inclusion criteria were fulﬁlled. The references of the identiﬁed papers
were cross-checked for unidentiﬁed articles.
Screening process showed in the prisma chart: two independent
reviewers screened187papers retrieved from electronic and manual
search for possible inclusion in the review. 151 articles are excluded on
the base of title and abstract. 27 articles are excluded on the base of
exclusion criteria.8 articles are included according to the inclusion
criteria.
2.2. Study eligibility

• Inclusion criteria: randomized control trial or retrospective studies
•

on open sinus lift and bone grafting. Adult, Medically Free, Sinus
approximation 2–6 mm and In English
The following exclusion criteria were applied: Pediatric, Medically
Compromised, Invitro, Autogenous Graft, metanalysis.

3. Results
Initial search reviewed 197 paper from electronic search (pup med
& Cochrane)&37 papers from manual search, 187 paper is present after
ﬁltration &duplication removal, 152 paper were excluded from title &
abstract, remaining 35 articles were reviewed as full text articles, 27
paper were excluded according to the exclusion criteria, 8 articles were
included in the study according to the inclusion criteria(Fig. 1) (Tables
1 and 2).
3.1. Reviewing & data extraction
Two independent researchers reviewed the selected 8 full text articles. 139 patients were included in all reviewed articles. The articles
were analyzed as per overall study design and data mining of the articles included the collection of the following data: number of patients
136
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Fig. 1. The prisma ﬂow diagram.

in each article, age, gender, amount of residual alveolar bone
(< 7 mm), type of graft used, time of implant placement and core bone
biopsy retrieval and the amount of bone gain (as percentage or in
millimeters).
Histological evaluation of newly formed bone showed 26.4% newly
formed bone, 27.3% residual graft material, and 46.3% bone marrow in
Kolerman et al. (2012) article [27]; while Stavropoulos A. et al. (2011)
had an average of 28–31.8% newly formed bone, 6.3–16.5% residual
graft, and the new bone was primarily woven and characterized by
slender trabeculae and narrow osteoid zones, and in many instances
bone was in contact with residual biomaterial particles [28]. On the
other hand, Martinez et al. (2010) documented average newly formed
bone of 35%, and residual graft of 32.6–34.8 ± 6.2–10.5%. Englrbert
A et al. (2013) demonstrated 19–24% bone gain with a 19% residual
bone [31]. Contrary to the reported high regenerated bone levels of
48% reported by Canullo L et al. (2009) at 6 months and 28% residual
graft and 24% bone marrow. Histomorphometric analysis of diﬀerent
bone grafts by Susanna Annibali et al. (2014) reported newly formed
bone ranging from as low as: 16.4% using mineralized solvent-dehydrated bone allograft (MSDBA) and as high as: 21.9% using equine bone
(EB) [33]. On contrary, were the recent results of Claudio Stacchi et al.
(2017) that demonstrated 34.9 ± 15% (NHA) 38.5 ± 17% (ABB) of
vital bone and 20.6 ± 13% (NHA). ± 12% (ABB) of residual graft
material & an overall 12 months loading success rate of 96.4% [34].
Radiographic studies as that of Jae-Kook Cha et al. (2011) reported
sinus ﬂoor heights of a mean3to4mm42 months with an insigniﬁcant
loss of 0.83 ± 0.38 mm [29].while Kolerman et al. (2012)augmented
sinus ﬂoor of remaining alveolar height of 5 mm up to18 mm he used
C.T scan to evaluate height in mm & area in mm2 [27] englrbert A et al.,
2013 reported increase in bone height ranges from 7.2 to 7.8 mm when
sinus ﬂoor of less than 7 mm he used panoramic x ray for evaluation of
bone height gain [31].

Published by Arab Journals Platform, 2018

4. Discussion
Bone resorption following tooth extraction or due to advanced
periodontal disease, and/or pneumatization of the maxillary sinus may
result in insuﬃcient bone in horizontal and/or more frequently, vertical
dimension for the placement of dental implants in the posterior maxilla.
Augmentation of the maxillary sinus ﬂoor (or sinus lift) with bone grafts
and/or substitutes is nowadays a standard treatment approach for reestablishing an adequate bone volume in the posterior maxilla. Bone
resorption following tooth extraction or due to advanced periodontal
disease, and/or pneumatization of the maxillary sinus may result in
insuﬃcient bone in horizontal and/or more frequently, vertical dimension for the placement of dental implants in the posterior maxilla.
Prosthodontic rehabilitation through dental endosseous implants in
the area of the posterior maxilla often fails due to an insuﬃcient bone
supply. To improve bone volume to support dental implants, tissue
formation is commonly enhanced by autologous bone grafting, often
combined with synthetic, resorbable materials.
In the present systematic review 8 articles were included according
to the inclusion criteria, these articles were reviewed at which 139
patient were included in this review, these patients have open sinus lift
procedure, with bone graft to augment the sinus followed by implant
placement in a second surgery after a period from 3 to 6 months,
radiological analysis were performed using C.B.C.T or C.T scan or panorama, during implant placement core bone biopsy were retrieved &
analyzed either for histological and histomorphometric analysis, the
sinuses for the 139 patients were augmented with various grafting
materials.
7 articles have histological results in percentages for the newly
formed bone &the amount of residual graft material, the highest level of
bone gain was reported of 48% reported by Canullo L et al. (2009) after
6 months of grafting who used nanocrystalline hydroxyapatite silica gel
[32] & the lowest level of bone gain was reported Susanna Annibali
et al. (2014) reported newly formed bone of 16.4% using (MSDBA)
137
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Table 1
List of excluded articles after reviewing.
Authors

Article name

1 Walter C, Mang WL Daculsi G et al.
Daculsi G, Bouler JM, LeGeros RZ

Artiﬁcial bone (tricalcium phosphate) in facial surgery (author's transl).
1 Adaptive crystal formation in normal and pathological calciﬁcations in
synthetic calcium phosphate and related biomaterials..
2 Bone-added osteotome technique versus lateral approach for sinus ﬂoor
elevation: a comparative radiographic study..

2 Kim SM, Park JW, Suh JY, Sohn DS, Lee JM

3 Cortes AR, Cortes DN, Arita ES
4 Arasawa M, Oda Y, Kobayashi T, Uoshima K, Nishiyama H,
Hoshina H, Saito C
5 Nery EB, Pﬂughoeft FA, Lynch KL, Rooney GE.
6 Nery EB, Pﬂughoeft FA, Lynch KL, Rooney GE.
7 Degidi M, Piattelli A, Perrotti V, Iezzi G.

8 Cricchio G, Palma VC, Faria PE, de Olivera JA, Lundgren S,
Sennerby L, Salata LA
9 Kolerman R, Samorodnitzky-Naveh GR, Barnea E, Tal H.

10 Schmelzeisen R, Gutwald R, Oshima T, Nagursky H, Vogeler M,
Sauerbier S
11 Jensen T, Schou S, Stavropoulos A, Terheyden H, Holmstrup P
12 Özkan Y, Akoğlu B, Kulak-Özkan Y
13 Lee DZ, Chen ST, Darby IB.
14 Antonaya-Mira R, Barona-Dorado C, Martínez-Rodríguez N,
Cáceres-Madroño E, Martínez-González JM
15 Cabezas-Mojón J, Barona-Dorado C, Gómez-Moreno G,
Fernández-Cáliz F, Martínez-González JM
16 Esposito M, Cannizzaro G, Soardi E, Pistilli R, Piattelli M,
Corvino V, Felice P
.17 Hart KL, Bowles D

18.Perelli M, Abundo R, Corrente G, Saccone C
19 Butz F, Bächle M, Ofer M, Marquardt K, Kohal RJ

21 Schuller-Götzburg P, Entacher K, Petutschnigg A, Pomwenger W,
Watzinger F
22.Petruzzi M, Ceccarelli R, Testori T, Grassi FR
23 Sauerbier S, Rickert D, Gutwald R, Nagursky H, Oshima T, Xavier
SP, Christmann J, Kurz P, Menne D, Vissink A, Raghoebar G,
Schmelzeisen R, Wagner W, Koch FP.
24 Szivek JA, Anderson PL, Dishongh TJ, DeYoung DW.
25 Sijeet singh, hemant gupta, deepka kumar
26 J. Mehta, A. El-Ghannam, C. Q. Ning.
27 AEl-Ghannam,LarryCunningham, David Pienkowski.

Reason for exclusion

Cone beam computed tomographic evaluation of a maxillary alveolar ridge
reconstruction with iliac crest graft and implants.
Evaluation of bone volume changes after sinus ﬂoor augmentation with
autogenous bone grafts.
Functional loading of bioceramic augmented alveolar ridge–a pilot study.
Functional loading of bioceramic augmented alveolar ridge–a pilot study.
Histologic and histomorphometric evaluation of an implant retrieved 8
years after insertion in a sinus augmented with anorganic bovine bone and
anorganic bovine matrix associated with a cell-binding peptide: a case
report.
Histological outcomes on the development of new space-making devices for
maxillary sinus ﬂoor augmentation..
3 Histomorphometric analysis of newly formed bone after bilateral
maxillary sinus augmentation using two diﬀerent osteoconductive
materials and internal collagen membrane.
Making bone II: maxillary sinus augmentation with mononuclear cells–case
report with a new clinical method.
1 Maxillarysinusﬂooraugmentation with Bio-Oss or Bio-Oss mixed with
autogenous bone as graft in animals: a systematic review.
Maxillary sinus ﬂoor augmentation using bovine bone grafts with
simultaneous implant placement: a 5-year prospective follow-up study.
4 Maxillary sinus ﬂoor elevation and grafting with deproteinized bovine
bone mineral: a clinical and histomorphometric study.
Meta-analysis of the increase in height in maxillary sinus elevations with
osteotome.
5 Meta-analyticstudy of implant survival following sinus augmentation.
Posterior atrophic jaws rehabilitated with prostheses supported by 6 mmlong, 4 mm-wide implants or by longer implants in augmented bone.
Preliminary results from a pilot randomized controlled trial.
6 Reconstruction of alveolar defects using titanium-reinforced porous
polyethylene as a containment device for recombinant human bone
morphogenetic protein.
1 Short (5 and 7 mm long) porous implants in the posterior atrophic
maxilla: a 5-year report of a prospective single-cohort study.
1 Sinus augmentation with bovine hydroxyapatite/synthetic peptide in a
sodium hyaluronate carrier (PepGen P-15 Putty): a clinical investigation
of diﬀerent healing times.
7 Sinus elevation with a cortical bone graft block: a patient-speciﬁc threedimensional ﬁnite element study.
Sinus ﬂoor augmentation with a hydropneumatic technique: a retrospective
study in 40 patients
8 Bone marrow concentrate and bovine bone mineral for sinus ﬂoor
augmentation: a controlled, randomized, single-blinded clinical and
histological trial–per-protocol analysis.
1 Evaluation of factors aﬀecting bonding rate of calcium phosphate
ceramic coatings for in vivo strain gauge attachment.
Immediate implant placement along with bone graft and delayed implant
placement in grafted socket:comparative study
Cyclosilicate nanocomposite: A novel resorbable bioactive tissue
engineering scaﬀold for BMP and bone-marrow cell delivery
Bone Engineering of the Rabbit Ulna

mineralized solvent dehydrated bone allograft [33], while the lowest
amount of residual material was reported in Stavropoulos A. et al.
(2011) was 6.3% residual graft in the recombinant human growth
factor and diﬀerentiation factor-5-coated tricalcium phosphate (rhGDF5/b-TCP)/4-month group [28] & the highest amount of residual material 34.8 ± 10.5.% for anorganic bovine-bone derived (ABB) reported by Martinez et al. (2010) [30].
So it is clear that the rate of new bone formation & the amount of
residual material depends on the type of material used& its rate of resorption as the technique of sinus lift is similar in the patients included
in the 7 articles & methods of histological evaluation is almost the same.
On the other hand radiographic evaluation was conducted in 2

https://digitalcommons.aaru.edu.jo/fdj/vol4/iss2/6

1 Artiﬁcial bone
2 Synthetic calcium
phosphate
3 Bone marrow
concentrate and bovine
bone mineral
2 Sinus lift techniques
Autogenous Graft, ridge
reconstruction
Autogenous Graft
Autogenous Graft
augmented alveolar ridge

Diﬀerent bone graft
Diﬀerent bone graft

1 Diﬀerent bone graft
2 Diﬀerent bone graft
1 Autogenous Graft
Diﬀerent bone graft
1 Diﬀerent bone graft
Sinuslift without bone graft
sinus lift without bone graft

Sinuslift without bone graft

Sinuslift without bone graft
Without sinus lift

Autogenous bone graft
1 Autogenous bone graft
Diﬀerent bone graft

Diﬀerent bone graft
No sinus lift
Invitro
experimental

articles beside the histological evaluation Kolerman et al. (2012) &
(englrbert A et al., 2013) measured increase in height in term of mm.
The increase in height ranges from 7 up to 18 mm [27,31].
While only one article used the radiographic evaluation without
histological evaluation (Jae-Kook Cha et al., 2011) this study use
Osteon, as a bone graft material, and to assess the height of the grafted
material through radiographic evaluation. In this study the author used
panoramic and intraoral ﬁlms for evaluation of the rate of resorption of
the grafted material this radiograph is a two dimensions tool which is
not accurate to determine the rate of bone changes, the three dimension
C.T scan is the recommended method for evaluation of bone changes
[29].
138
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12

31

20

Kolerman et al.
[27]

Stavropoulos A
et al. [28]

Jae-Kook Cha
et al. [29]
Martineza et al.
[30]

139

12

16

4 patients

28 patients

englrbert A et al.
[31]

Canullo L et al.
[32]

Susanna Annibali
et al., 2014
[33]

Claudio Stacchi
et al. [34]

16

Sample size

Article

Table 2
List of included articles.

18

3

-

10

mean age 52
years, range
36–70

36–73y

-

–

41–65.9
years

42–80 years

38–67y

1

15

7

F

Age

-

–

16

5

M

Gender

3–6mm

Atrophied
maxilla Less
than 3 mm

Nanohydroxyapatite, anorganic bovine
bone

(HA-..-TCP 30/70), anorganic bovine
bone (ABB), mineralized solventdehydrated bone allograft (MSDBA),
and equine bone (EB),

nanocrystalline hydroxyapatite silica
gel

βTCP 60% 0.7–1.4 mm,
Resorbablecollagenous membrane
25 × 25 mm

≤7 mm

1–3 mm

ABB, TCP 1.6 ± 0.4 cm

2

6 months

After 6
months

6 months

8 months

6 months

3–4 months

rhGDF-5/b-TCP. β-TCP/AB.

Osteon 0.5–1 mm 1–2 mm

9 months

Time of
implant
placement

HA:_-TCP 0.5–1 mm

Material used&particle size

3.8 mm

4-3 mm

5 mm

5 mm

Residual
alveolar bone
%

30.2% newly formed bone for Ha-.-TCP 30/
70, 20.1% for ABB, 16.4% for MSDBA, and
21.9%for EB. Residual material (HA-..-TCP30/70). 29.1%, (ABB). 19.1%, (MSDBA)
18.5%, (EB)23.2%.
Newly formed bone 34.9 ± 15% (NHA)
38.5 ± 17% (ABB) and residual graft
20.6 ± 13% (NHA) 22.3 ± 12% (ABB)

24% bone gain with membrane&19%
without Residual bone 19% (without
membrane: 7.8 ± 1.9 mm; with membrane:
7.2 ± 1.5 mm; mean ± SD).
48 ± 4.63% newly formed bone
28 ± 5.33%, residual material

35% of new bone formed for both groups
remaining presence of TCP particles was
32.6 ± 6.2% and 34.8 ± 10.5.% for APP

26.4% newly formed
bone 27.3% residual
graft
31.4% in the rhGDF-5/b-TCP. 28% in the
rhGDF-5/b-TCP. 31.8% in the b-TCP/AB
group. The proportion of remaining b-TCP
averaged 12.6% in the rhGDF-5/b-TCP/3month group, 6.6% in the rhGDF-5/b-TCP/
4-month group, and 16.5% in the b-TCP/AB
group.
S0.81 ± 0.43 mm L0.85 ± 0.33 mm

6–18 mm

Mm

Outcome Measures (bone gain)

C.B.C.T. HU
Toulodine blue

computerized
tomography (CT)
SCAN H.U Touldine
blue

High resolution
micro CT

Height, Width (in
mm) Area (in mm2)

CT

Alizarin red
stain using
Image J
software Signal
Intensity

Alizarin red
stain using
Image J
software Signal
Intensity

Image J
software Signal
intensity
Alizarin red
stain using
Image J
software Signal
Intensity

Alizarin

Device, Unit of measure

mm

mm

pa

R.C.T

R.C.T

R.C.T

R.C.T

R.C.T

R.C.T

R.C.T

Study design
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augmentation of the maxillary sinus ﬂoor? Clin Oral Implants Res 2005;16:349–56.
[15] Hallman M, Caderlund A, Lindscog S, Lundsgren S, Sennerby L. A clinical histologic
study of bovine hydroxyapetite in combination with autogenous bone and ﬁbrin
glue for maxillary sinus augmentation. Clin Oral Implants Res 2001;12:135–46.
[16] Norton RM, Odell EW, Thompson ID, Cook RJ. Eﬃcacy of bovine bone mineral for
alveolar augmentation: a human histologic study. Clin Oral Implants Res
2003;14:775–83.
[17] Mellonig IT, Bovers GM, Baily R. Comparison of bone graft materials. Part 1. New
bone formation with autografts and allografts determined by Strontium 85. J
Periodontol 1991;52:291–6.
[18] Mellonig IT, Bovers GM, Cotton W. Comparison of bone graft materials. Part 2. New
bone formation with autografts and allografts: a histologic evaluation. J Periodontol
1981;52:297–304.
[19] Glowacki J, Mulliken JB. Demineralized bone implants. Clin Plast Surg 1985;12.
233–233.
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5. Conclusion
For the clinical point of view the present systematic review supported the fact that open sinus lift with grafting with bone substitute act
as scaﬀold for a new bone formation leading to formation of new bone
but we need further research on diﬀerent types of bone grafts to improve its character and to improve the nature of the newly formed bone.
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